Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04561375 · ClinicalTrials.gov registry record · Phase 4
Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery
A Phase 4 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT04561375: Clinical Trial Phase 4 study, sponsored by The Cleveland Clinic.
NCT04561375 is a Phase 4 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 61 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04561375, a Phase 4 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.
Primary Outcome
The total amount of fentanyl consumed in PACU.
Interventions
- DRUG Fentanyl
- DRUG Sufentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-12-11 |
| Est. Completion | 2022-07-01 |
| Phase | Phase 4 |
Why NCT04561375 stopped before completion
NCT04561375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Fentanyl is the first listed.
NCT04561375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04561375 about?
NCT04561375 is a clinical study titled "Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery". A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.
What is the current status of trial NCT04561375?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2020-12-11. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04561375?
The interventions under investigation include: Fentanyl (DRUG), Sufentanil (DRUG).
Who is sponsoring clinical trial NCT04561375?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04561375's enrollment target sits among peer trials
61 1119th of 2000 higher than 876 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI